BPA Call HHSF223201610016B-75F40119F19001
Award Date
8/1/19
Potential Completion Date
7/31/20
Potential Value
$7M
Federal Agency
Food and Drug Administration
Awardee
Accenture Federal Services LLC
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
2
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract was awarded by the Food and Drug Administration (FDA) to Accenture Federal Services LLC, doing business as Accenture National Security Services, for architecture and process modernization support services for the FDA's Center for Drug Evaluation and Research (CDER) informatics program management office. The contract has a ceiling value of $18,507,262.24 and a completion date of July 5, 2022. It is a Blanket Purchase Agreement (BPA) call order under the FDA Safety and Innovation Act...
This is a federal contract award from the Food and Drug Administration (FDA) to Accenture Federal Services LLC, doing business as Accenture National Security Services, for $6,476,688.66 over a two-year period ending on August 9, 2024. The contract, which is a Blanket Purchase Agreement (BPA) call placed under Accenture's existing Multiple Award Schedule (MAS) contract, is for scientific and operational support services for the FDA's Center for Drug Evaluation and Research (CDER). The contract is...
This is a $12,644,112.90 Firm Fixed Price BPA Call contract awarded by the Food and Drug Administration (FDA) to Accenture Federal Services LLC, a subsidiary of the global professional services firm Accenture plc. The contract is for the CDER PMO AND INFORMATICS GOVERNANCE MODERNIZATION PROJECT, which involves providing IT services and support for the FDA's Center for Drug Evaluation and Research (CDER). The contract does not have a set-aside designation. As part of this contract, Accenture...
This is a $2,587,360.14 delivery order contract awarded to Accenture Federal Services LLC by the Food and Drug Administration (FDA). The contract is for enterprise data governance services for the FDA's Center for Drug Evaluation and Research (CDER) and uses the Alliant II Government-Wide Acquisition Contract (GWAC) as the parent contract vehicle. The contract has a period of performance that runs through February 24, 2025 and is on a time and materials pricing basis. Accenture Federal Services,...
This federal contract award, valued at $8,713,885.22, was granted by the Food and Drug Administration (FDA) to Accenture Federal Services LLC, doing business as Accenture National Security Services. The contract, which is not a set-aside, is for business process improvements and implementation support, and is a Blanket Purchase Agreement (BPA) call under Accenture's existing Multiple Award Schedule (MAS) contract with the General Services Administration (GSA). Accenture has enlisted Vergys...
This federal contract award, with an ID of 75F40121A00001|75F40123F19004, was made by the Food and Drug Administration to Accenture Federal Services LLC for BUSINESS TRANSFORMATION TEAM (BTT) SUPPORT SERVICES. The contract is a Blanket Purchase Agreement (BPA) Call awarded under the Multiple Award Schedule (MAS) vehicle. The total ceiling value of the contract is $6,333,945.13, with a period of performance through June 24, 2026. The contract is not set aside. Accenture Federal Services, a...
The Department of Health and Human Services Food and Drug Administration awarded a $6.4 million firm fixed price delivery order contract to Accenture Federal Services LLC for business process improvement support services. Accenture will draw upon its Multiple Award Schedule contract vehicle to provide services assisting the FDA's Center for Devices and Radiological Health. One subcontract for procurement support was issued to Vergys LLC. The three-year contract will see Accenture and its...
This is a Blanket Purchase Agreement (BPA) call awarded by the Food and Drug Administration (FDA) to Accenture Federal Services LLC, a global professional services company, to provide program management support for the FDA's Enterprise Transformation Office (ETO). The purpose is to support the ETO's objectives in driving business process changes across the FDA. The contract has a ceiling value of $4,351,414.94 and a performance period through June 12, 2024. The contract was awarded under the...
This is a firm fixed-price contract awarded by the Food and Drug Administration (FDA), a civilian agency, to Accenture Federal Services LLC, a subsidiary of the global professional services firm Accenture plc. The contract is for CLINICAL DATA SAFETY ANALYSIS services with an ultimate completion date of April 27, 2027 and a ceiling value of $1,894,776.76. The contract was awarded on April 23, 2025 and was placed as a call against Accenture's existing Multiple Award Schedule (MAS) contract with...
This $4,764,927.70 federal contract award was issued by the Food and Drug Administration (FDA) to Deloitte Consulting LLP, a management and technology consulting firm, under the Information Technology Schedule 70 (IT-70) contract vehicle. The contract is for a BPA call order to provide IT services and support for the FDA's Center for Drug Evaluation and Research (CDER) Integrity program. The award does not have a set-aside designation. The contract involves Deloitte providing a range of...